Open AccessFirst-Line Treatment Options for CLL
Author(s) -
William G. Wierda
Publication year - 2017
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000527164.52463.9e
Subject(s) - ibrutinib , chemoimmunotherapy , chronic lymphocytic leukemia , idelalisib , medicine , bruton's tyrosine kinase , oncology , first line treatment , venetoclax , leukemia , tyrosine kinase , chemotherapy , receptor